Authors:
Pujol, JL
Daures, JP
Riviere, A
Quoix, E
Westeel, V
Quantin, X
Breton, JL
Lemarie, E
Poudenx, M
Milleron, B
Moro, D
Debieuvre, D
Le Chevalier, T
Citation: Jl. Pujol et al., Etoposide plus cisplatin with or without the combination of 4 '-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: A French federation of cancer institutes multicenter phase III randomizedstudy, J NAT CANC, 93(4), 2001, pp. 300-308
Authors:
Quoix, E
Breton, JL
Daniel, C
Jacoulet, P
Debieuvre, D
Paillot, N
Kessler, R
Moreau, L
Coetmeur, D
Lemarie, E
Milleron, B
Citation: E. Quoix et al., Etoposide phosphate with carboplatin in the treatment of elderly patients with small-cell lung cancer: A phase II study, ANN ONCOL, 12(7), 2001, pp. 957-962
Authors:
Debrix, I
Tilleul, P
Milleron, B
Grene, N
Bouleuc, C
Roux, D
Liote, H
Madelaine, I
Bellanger, A
Conort, O
Fontan, JE
Le Mercier, F
Bardin, C
Becker, A
Citation: I. Debrix et al., The relationship between introduction of American Society of Clinical Oncology guidelines and the use of colony-stimulating factors in clinical practice in a Paris university hospital, CLIN THER, 23(7), 2001, pp. 1116-1127
Authors:
Bardet, E
Moro-Sibilot, D
Le Chevalier, T
Massard, G
Douillard, JY
Theobald, S
Astoul, P
Baldeyrou, P
Bazelly, B
Brechot, J
Breton, JL
Grivaux, M
Jacoulet, P
Khalil, A
Lemarie, E
Martinet, Y
Milleron, B
Paesmans, M
Pujol, JL
Quoix, AE
Ranfaing, E
Riviere, A
Sancho-Garnier, H
Souquet, PJ
Spaeth, D
Stoebner-Delbarre, A
Thiberville, L
Touboul, E
Vaylet, F
Vergnon, JM
Westeel, V
Depierre, A
Lagrange, JL
Citation: E. Bardet et al., Standards, Options and Recommendations for the management of locally advanced non small cell lung carcinoma, B CANCER, 88(4), 2001, pp. 369-387
Authors:
Wislez, M
Fleury-Feith, J
Rabbe, N
Moreau, J
Cesari, D
Milleron, B
Mayaud, C
Antoine, M
Soler, P
Cadranel, J
Citation: M. Wislez et al., Tumor-derived granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor prolong the survival of neutrophils infiltrating bronchoalveolar subtype pulmonary adenocarcinoma, AM J PATH, 159(4), 2001, pp. 1423-1433
Authors:
Bennouna, J
Monnier, A
Riviere, A
Milleron, B
Lemarie, E
Trillet-Lenoir, V
Soussan-Lazard, K
Berille, J
Douillard, JY
Citation: J. Bennouna et al., A phase II study of docetaxel and vinorelbine combination chemotherapy in patients with advanced non-small cell lung cancer, EUR J CANC, 36(9), 2000, pp. 1107-1112
Authors:
Giraud, P
Antoine, M
Larrouy, A
Milleron, B
Callard, P
De Rycke, Y
Carette, MF
Rosenwald, JC
Cosset, JM
Housset, M
Touboul, E
Citation: P. Giraud et al., Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning, INT J RAD O, 48(4), 2000, pp. 1015-1024
Authors:
Zalcman, G
Tredaniel, J
Schlichtholz, B
Urban, T
Milleron, B
Lubin, R
Meignin, V
Couderc, LJ
Hirsch, A
Soussi, T
Citation: G. Zalcman et al., Prognostic significance of serum p53 antibodies in patients with limited-stage small cell lung cancer, INT J CANC, 89(1), 2000, pp. 81-86
Authors:
Wislez, M
Cadranel, J
Antoine, M
Milleron, B
Bazot, M
Mayaud, C
Carette, MF
Citation: M. Wislez et al., Lymphoma of pulmonary mucose-associated lymphoid tissue: CT scan findings and pathological correlations, EUR RESP J, 14(2), 1999, pp. 423-429
Authors:
Debrix, I
Bouleuc, C
Liote, H
Milleron, B
Beker, A
Citation: I. Debrix et al., Impact of American Society of Clinical Oncology guidelines for clinical use of colony-stimulating factors, J CL ONCOL, 17(10), 1999, pp. 3360-3361
Authors:
Debrix, I
Flahault, A
Becker, A
Schwartz, L
Kanfer, A
Milleron, B
Citation: I. Debrix et al., Impact of guidelines implemented in a Paris university hospital: application to the use of antiemetics by cancer patients, BR J CL PH, 48(4), 1999, pp. 616-622